![John Harlow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Harlow
President at
LARIMAR THERAPEUTICS, INC.
Net worth: 159 750 $ as of 2026-09-29
Profile
Mr. John B. Harlow is a President & Chief Operating Officer at Larimar Therapeutics, Inc. Mr. Harlow was previously employed as a Chief Commercial Officer by Esperion Therapeutics, Inc., a Chief Commercial Officer by Melinta Therapeutics, Inc., a Chief Commercial Officer & Executive VP by Baudax Bio, Inc., an Executive Vice President-Commercial by Recro Pharma, Inc., a Vice President & General Manager-Pain Business by Endo Pharmaceuticals, Inc., a Vice President-Sales & Marketing by Shionogi, Inc., and a Senior Director-Marketing by King Pharmaceuticals, Inc. He received his undergraduate degree from Lehigh University and an MBA from Stillman School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-09-28 | 50,000 ( 0.06% ) | 159 750 $ | 2026-09-29 |
John Harlow active positions
| Companies | Position | Start |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | President | 2026-09-28 |
Former positions of John Harlow
| Companies | Position | End |
|---|---|---|
| MELINTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2025-10-31 |
| BAUDAX BIO, INC. | Corporate Officer/Principal | 2021-02-28 |
| SOCIETAL CDMO, INC. | Corporate Officer/Principal | 2019-10-31 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 2015-12-31 |
KP Pharmaceuticals LLC
 KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Sales & Marketing | 2011-05-31 |
Education of John Harlow
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
54
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
KP Pharmaceuticals LLC
KP Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures, markets and sells generic pharmaceutical products | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Societal CDMO, Inc.
 Societal CDMO, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Stillman School of Business
 Stillman School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baudax Bio, Inc.
 Baudax Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for acute care settings | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage company and develops innovative therapies for acute and life-threatening illnesses | Health Technology |
Larimar Therapeutics, Inc.
 Larimar Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on developing treatments for complex rare diseases | Health Technology |
- Stock Market
- Insiders
- John Harlow
